Cloudbreak Pharma, Inc. · OTC:CDBKF

Cloudbreak Pharma, Inc. financial statements

Cloudbreak Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022
Revenue010.0M00
Research and development66.8M37.9M27.5M15.3M
Selling, general and administrative40.9M9.49M2.62M5.42M
Operating income-107.4M-37.2M-35.8M-23.7M
Depreciation and amortization620.0K1.23M829.0K329.0K
EBITDA-106.8M-36.0M-34.9M-23.4M
Interest expense23.0K27.0K275.0K31.0K
Income before tax-67.8M-98.3M-129.4M-66.8M
Net income-67.7M-99.1M-129.4M-66.8M
Earnings per share, basic-0.08-0.12-0.15-0.08

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents40.1M34.9M52.7M15.9M
Short-term investments18.2M7.50M63.2M
Inventory110.0K0
Current assets64.3M37.5M61.5M80.1M
Total assets66.6M40.0M64.8M82.1M
Accounts payable836.0K1.76M2.10M1.23M
Current liabilities6.02M391.3M327.4M226.7M
Total liabilities6.12M391.6M327.6M227.3M
Shareholders' equity60.5M-351.5M-262.8M-145.2M
Shares outstanding844.6M838.9M838.9M838.9M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-51.5M-26.5M-22.5M-20.1M
Capital spending-18.2M-155.0K-2.21M-778.0K
Free cash flow-69.7M-26.7M-24.7M-20.8M
Change in cash5.02M-17.6M36.9M-64.2M